Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq
AMA 10th edition
In-text citation: (1), (2), (3), etc.
Reference: Hasan SA, Najati AM, Abass KS. Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasia J Biosci. 2019;13(2), 1045-1050.

APA 6th edition
In-text citation: (Hasan et al., 2019)
Reference: Hasan, S. A., Najati, A. M., & Abass, K. S. (2019). Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasian Journal of Biosciences, 13(2), 1045-1050.

Chicago
In-text citation: (Hasan et al., 2019)
Reference: Hasan, Sarah Ahmed, Ali Mohamed Najati, and Kasim Sakran Abass. "Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq". Eurasian Journal of Biosciences 2019 13 no. 2 (2019): 1045-1050.

Harvard
In-text citation: (Hasan et al., 2019)
Reference: Hasan, S. A., Najati, A. M., and Abass, K. S. (2019). Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasian Journal of Biosciences, 13(2), pp. 1045-1050.

MLA
In-text citation: (Hasan et al., 2019)
Reference: Hasan, Sarah Ahmed et al. "Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq". Eurasian Journal of Biosciences, vol. 13, no. 2, 2019, pp. 1045-1050.

Vancouver
In-text citation: (1), (2), (3), etc.
Reference: Hasan SA, Najati AM, Abass KS. Isolation and identification of multi-drug resistant “pseudomonas aeruginosa” from burn wound infection in Kirkuk City, Iraq. Eurasia J Biosci. 2019;13(2):1045-0.

Abstract

Background:P. aeruginosa” is considered as ubiquitous bacteria that can rapidly obtain resistance against various wide spectrum antibiotics It can rapidly obtain resistance against various wide spectrum antibiotics which lead to problematic conditions. This study was proceeded with an aim to determine the antibacterial resistance pattern and prevalence of “MDR P. aeruginosa” infection among burns patients.
Material and Methods: This study was carried out on the Burn patients in Azadi Teaching Hospital in Kirkuk city / IRAQ from January, 2016 to June, 2016. The clinical samples were collected using sterile cotton swabs from 100 patients with burn wound infections. “P. aeruginosa” was identified by using standard microbial methods. The drug susceptibility pattern using 10 different antibiotics (Augmentin, Amoxicillin, Ceftriaxone, Cefotaxime, Ceftazidime, Tetracycline, Gentamycin, Imipenem, Ciprofloxacin and Amikacin) was performed for all the isolates using Kirby Bauer’s Disc Diffusion Method.
Results: “P. aeruginosa” were isolated from 36clinical burn samples and88.88% of these isolates were Multidrug Resistance “P. aeruginosa” (MDRPa). Resistance rates to different antibiotics were as follows: 36 (100%) resistant to (Augmentin, Amoxicillin, Ceftriaxone and Cefotaxime), 19 (53%) isolates showed resistance towards Ceftazidime, 33 (92%) isolates were resistant towards (Tetracycline, Gentamycin and Imipenem). Ciprofloxacin and Amikacin resistance were seen in 31 (89%) and 24 (67%) isolates respectively.
Conclusion: Wide prevalence of MDRPa and nosocomial infections submit continuous monitoring of burn infections and evolve new strategies for drug resistance control and treatment of infections.

References

  • Al-Jassser AM, Elkhizzii NA (2004) Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa. Saudi med J, 25(6): 780-784.
  • Biswal I, Arora BS, Kasana D, Neetushree (2014) Incidence of Multidrug Resistant “Pseudomonas aeruginosa” Isolated from Burn Patients and Environment of Teaching Institution. Journal of Clinical and Diagnostic Research, 8(5): DC26-DC29. https://doi.org/10.7860/JCDR/2014/7483.4383
  • Carmeli YN, Troillet G, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: Comparison of risks associated with different antipseudomonal agents. Antimicrob. Agents Chemother, 3: 1379–82. https://doi.org/10.1128/AAC.43.6.1379
  • CDC-Centers for Disease Control and Prevention (2010) Antibiotic resistance questions and answers. Retrieved from http://www.cdcgov/getsmart/antibiotic-use/anitbiotic-resistance-faqs.html
  • Church D, Elsayed S, Reid O, Winston B, Lindsay R (2006) Burn wound infections. J Clin. Microbiol. Rev, 19(2): 403-434. https://doi.org/10.1128/CMR.19.2.403-434.2006
  • Clinical and Laboratory Standards Institute (CLSI) (2011) Performance standards for antimicrobial susceptibility testing; Twenty first Informational supplement. M100-S21. Wayne, PA: CLSI.
  • Collee JG, Fraser AG, Marmion BP, Simmons A (1996) Mackie and McCartney Practical Medical Microbiology. 14th ed. Edinburgh: Churchill Livingstone.
  • Dale RMK, Schnell G, Wong JP (2004) Therapeutic efficacy of antibiotics against burn wound infection by “Pseudomonas aeruginosa”. Antimicrob. Agents Chemother, 48(8): 2918-2923. https://doi.org/10.1128/AAC.48.8.2918-2923.2004
  • Ekrami A, Kalantar E (2007) Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res 126: 541-4.
  • Ekrem K, Rokan DK (2014) Antibiotic susceptibility patterns of “Pseudomonas aeruginosa” strains isolated from various clinical specimens. Sky J. Microbiol. Res., 2(2): 13-17.
  • Goossens H, Ferech M, Vander Stichele R, Elseviers M (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet, 365(9459): 79-87. https://doi.org/10.1016/S0140-6736(05)70799-6
  • Iduh UM, Chollom CS, Nuhu A, Spencer TH, Nura MB, Ashcroft OF (2015) Nosocomial infections in post-operative wounds due to Staphylococcus aureus and “Pseudomonas aeruginosa” in Benue State Nigeria. Afr. J. Microbiol. Res. 9(36):1989-1996. https://doi.org/10.5897/AJMR2014.6809
  • Iraj N, Azita T, Zinab F, Kobra A, Saeedeh R, Mojtaba H, Sirous A, Afshin A (2013) Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran. Iran J Microbiol, 5(1): 36-41.
  • Japoni A, Farshad S, Alborzi A (2009) Pseudomonas aeruginosa: Burn Infection, Treatment and Antibacterial Resistance. Iranian Red Crescent Medical Journal, 11(3): 244-253.
  • Jones RN, Kirby JT, Beach ML, Biedenbach DJ, Pfaller MA (2002) Geographic variations in activity of broad-spectrum lactams against Pseudomonas aeruginosa: Summary of the worldwide SENTRY antimicrobial surveillance program 1997–2000. Diagn. Microbiol. Infect. Dis., 43: 239-243. https://doi.org/10.1016/S0732-8893(02)00390-5
  • Lister PD, Wolter DJ, Hanson ND (2009) Antibacterial-Resistant Pseudomonas aeruginosa: Clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol., 22(4): 582-610. https://doi.org/10.1128/CMR.00040-09
  • Magiorakos AP (2011) Multidrug Resistant (MDR), Extensively Drug Resistant (XDR) and Pandrug-1 Resistant (PDR) bacteria in healthcare settings. Expert Proposal for a Standardized International Terminology. Available online at www.escmid.org
  • Moazami-Goudarzi S, Eftekhar F (2012) Assessment of carbapenem susceptibility & multidrug resistance in “Pseudomonas aeruginosa” in burn isolates. Jundishapur J Microbiol, 6: 162-5. https://doi.org/10.5812/jjm.5036
  • Naqvi ZA, Hasmi K, Rizwan QM, Kaarat SA (2005) Multidrug resistance in Pseudomonas aeruginosa: A healthcare associated infection threat in burn patient. Pak J Pharmacol, 22: 9-15.
  • Naqvi ZA, Hasmi K, Rizwan QM, Kaarat SA (2005) Multidrug resistance in Pseudomonas aeruginosa: A healthcare associated infectio threat in burn patient. Pak J Pharmacol, 22: 9-15.
  • Nikaido H (1989) Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother, 33(11): 1831-1836. https://doi.org/10.1128/AAC.33.11.1831
  • Obritsch MD, Fish DN, MacLaren R, Jung R (2004) National surveillance of antimicrobial resistance in “Pseudomonas aeruginosa” isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother, 48: 4606-10. https://doi.org/10.1128/AAC.48.12.4606-4610.2004
  • Obritsch MD, Fish DN, MacLaren R, Jung R (2005) Nosocomial infection due to Multidrug Resistant P.aeruginosa. Epidemiology and Treatment options. Pharamacotherapy, 25(10): 1353-1364. https://doi.org/10.1592/phco.2005.25.10.1353
  • Okon K, Agukwe P, Oladosu W, Balogun S, Uba A (2009) Antibiotic resistance pattern of “Pseudomonas aeruginosa” isolated from clinical specimens in a tertiary hospital in northeastern Nigeria. J. Microbiol., 8(2): 5-7. https://doi.org/10.5580/a34
  • Orrett FA (2004) Antimicrobial susceptibility survey of “Pseudomonas aeruginosa” strains isolated from clinical sources. J. Natl. Med. Assoc., 96(8): 65-69.
  • Pathmanathan SG, Samat NA, Mohamed R (2009) Antimicrobial susceptibility of clinical isolates of “Pseudomonas aeruginosa” from a Malaysian Hospital. Malays J Med Sci, 16(2): 27-32.
  • Pier GB, Ramphal R (2010) Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier. p. 2835-60. https://doi.org/10.1016/B978-0-443-06839-3.00219-8
  • Poole K, Krebes K, McNally C, Neshat S (1993) Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol, 175(22): 7363. https://doi.org/10.1128/jb.175.22.7363-7372.1993
  • Ramprasad BP, Marissa R, Suprama D (2010) Role of Pseudomonas in Nosocomial Infections and Biological Characterization of Local Strains. J Biosci Tech., l1(4): 170-9.
  • Saderi H, Falipour HL, Owalia P, Salimi H (2014) Detection of metallo β-lactamase producing “Pseudomonas aeruginosa” isolated from burn patient in Tehran, Iran. Lab Med, 41: 609-12. https://doi.org/10.1309/LMQJF9J3T2OAACDJ
  • Shewatatek G, Gizachew T, Molalegne B, Terefe G (2014) Drug sensitivity of “Pseudomonas aeruginosa” from wound infections in Jimma university specialized hospital, Ethiopia. J. Med. Med. Sci. Res., 3(2): 13-18.
  • Sule A, Thanni L, Sule-Odu O, Olusanya O (2002) Bacterial pathogens associated with infected wounds in Ogun state university teaching hospital, Sagamu, Nigeria. Afr. J. Clin. Exp. Microbiol., 3(1): 13-16. https://doi.org/10.4314/ajcem.v3i1.7344
  • Vahdani M, Azimi L, Asghari B, Bazmi F, Rastegar LA. Phenotypic screening of extended-spectrum ß-lactamase and metallo-ß-lactamase in multidrug-resistant “Pseudomonas aeruginosa”from infected burns. Ann Burns Fire Disasters. 2012;25(2):78-81.
  • WHO (2002) Humans. World Health Organization.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.